The Trusted Provider of Scientific
and Laboratory Services

Find a solution that will work for you.

Platform Technologies
Learn more

What's New
3/10/2014 - BioReliance scientist wins Editor's Choice Award from the Environmental Mutagenesis and Genomics Society.
The paper and article, involving Dr. Rohan Kulkarni and entitled, "Genotoxicity of Doxorubicin in F344 Rats by Combining the Comet Assay, Flow-Cytometric Peripheral Blood Micronucleus Test, and Pathway-Focused Gene Expression Profiling" appeared in the October issue of Environmental and Molecular Mutagenesis and will be highlighted on the cover of an upcoming edition.

10/16/2014 - BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy ST. LOUIS – October 16, 2014 – BioReliance® (, Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services business under SAFC® Commercial (, has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services for pharmaceutical, chemical and industrial consumer products to its service offering. The broad set of highly predictive assays use a novel suite of genetically modified cell lines created with CompoZr® zinc finger nuclease (ZFN), a Sigma-Aldrich proprietary technology.

Read more Press

Looking for a Specific Assay?

Start your search here.

example: Mycoplasma

How can we help?

US - Local: 301.738.1000

Toll Free: 800.756.5658

Click here to contact us